MDT perspectives on the role of incretin hormones in wellness and in T2D

touchMDT for touchENDOCRINOLOGY Listen to key experts from a multidisciplinary team discuss the role of incretin hormones in healthy individuals and in those with T2D and share insights from the latest research in this field  The multidisciplinary team Endocrinologist (obesity): Dr Ken Fujioka, San Diego, CA Endocrinologist (diabetes): Professor Carol Wysham, Spokane, WA This touchPODCAST is for HCPs only. This activity is funded by an unrestricted independent medical education grant from Eli Lilly. This activity is jointly provided by USF Health and touchIME. For further information visit: https://touchendocrinologyime.org/glycemic-control-weight-loss-in-t2d-obesity-incretin-based-dual-agonists/